Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says




Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *